Home/Pipeline/Immunology Collaboration (J&J)

Immunology Collaboration (J&J)

Immunology & Inflammation

Discovery/ResearchActive

Key Facts

Indication

Immunology & Inflammation

Phase

Discovery/Research

Status

Active

Company

Flexomics

About Flexomics

Flexomics is an early-stage biotech innovator building a unique functional genomics platform. Its core technology, centered on the FLEX picowell chip, enables researchers to culture, assay, and image live cells before performing single-cell RNA sequencing on the same sample, creating a direct link between cell behavior and molecular identity. The company, founded in 2020, operates as a private platform technology provider, securing non-dilutive funding through prestigious grants and industry partnerships to advance its tools for therapeutic discovery.

View full company profile

Therapeutic Areas

Oncology Immunology

Other Immunology & Inflammation Drugs

Drug	Company	Phase	Status
YUSIMRY® (adalimumab-fkjp)	Meitheal Pharmaceuticals	Approved	Active
PS-1001	Paratus Sciences	Pre-clinical	Active
TNFR1 Antagonist	AI Proteins	Discovery	Active
IMM-001	RapaFusyn Pharmaceuticals	Preclinical	Active
IMM-002	RapaFusyn Pharmaceuticals	Preclinical	Active
IMM-003	RapaFusyn Pharmaceuticals	Preclinical	Active